Insulet Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Financial Results and Raised Its FY25 Sales Guidance Above Estimates. Also, the Company Issued Q2 Sales Guidance Above Estimates.
Insulet Raises FY2025 Sales Guidance From $2.40B-$2.49B to $2.49B-$2.55B Vs $2.45B Est
FDA to Speed up AI Rollout to Accelerate Drug Reviews
Merck Boosts U.S. Investments With $895M Expansion in Kansas Site
Merck Animal Health Plans $895M Expansion in Kansas, Adding Jobs and Boosting Vaccine Production
Novo Nordisk Says Its 'Wegovy In A Pill' Delivers Big: '16.6% Average' Weight Loss, Over 20% For One-Third Of Adults Struggling With Obesity
Marjorie Taylor Greene Goes Stock Shopping Again: Here Are 50+ Stocks The Congresswoman Bought
Trump Planning on Executive Order to Further Cut Medicare Drug Prices - Report
Lilly Benefits as Judge Upholds FDA Removing Zepbound From Shortages List
Gilead to Invest About $32B in U.S. Manufacturing Through 2030
S&P 500's Five Most Overbought and Oversold Stocks
This House of Representative Just Bought Up To $915K In AbbVie Stock
Novo Nordisk's Wegovy Sales Surge 85% But Compounded Weight Loss Drugs In US Impacts Annual Outlook
Novo Nordisk Cuts 2025 Outlook. But Why Are Its Shares Rising?
Trump wants to impose tariffs on Pharmaceuticals: Pharmaceutical companies are busy stockpiling, and the import volume in the USA surged in March.
① The volume of Pharmaceutical imports in the USA surged in March, as pharmaceutical companies stockpiled products in anticipation of potential tariffs; ② A report released by the US Department of Commerce on Tuesday showed that the total value of Pharmaceutical imports in March exceeded 50 billion USD, equivalent to 20% of the total Pharmaceutical imports for the entire year of 2024.
Eli Lilly Stock Is Sliding Tuesday: What's Going On?
Trump Administration Cancels Meeting With FDA Workers Union - Report
Here's How Much You Would Have Made Owning Intuitive Surgical Stock In The Last 10 Years
Eli Lilly in Licensing Pact With Alchemab for ALS Program
'Trump To Sign Order To Encourage Domestic Drug Manufacturing' - Washington Post